Edgar M Carvalho Selected Research

Spinal Cord Diseases

12/2018	Local and systemic production of proinflammatory chemokines in the pathogenesis of HAM/TSP.
1/2016	Association of Sicca Syndrome with Proviral Load and Proinflammatory Cytokines in HTLV-1 Infection.
10/2008	Pentoxifylline down modulate in vitro T cell responses and attenuate pathology in Leishmania and HTLV-I infections.
4/2007	Urinary and sexual manifestations of patients infected by HTLV-I.
12/2005	Spontaneous neutrophil activation in HTLV-1 infected patients.
1/2004	Clinical and immunological consequences of human T cell leukemia virus type-I and Schistosoma mansoni co-infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edgar M Carvalho Research Topics

Disease

59	Cutaneous Leishmaniasis 03/2024 - 01/2002
38	Leishmaniasis 04/2023 - 12/2002
34	Infections 01/2024 - 05/2003
9	Inflammation (Inflammations) 12/2023 - 10/2008
8	Ulcer 07/2023 - 01/2002
7	Asthma (Bronchial Asthma) 02/2017 - 05/2003
6	Spinal Cord Diseases 12/2018 - 01/2004
6	Schistosomiasis (Bilharziasis) 01/2018 - 01/2002
6	Schistosomiasis mansoni 01/2014 - 01/2004
5	Hypersensitivity (Allergy) 01/2021 - 07/2005
5	Fibrosis (Cirrhosis) 01/2021 - 01/2004
4	Overactive Urinary Bladder (Overactive Bladder) 01/2022 - 11/2012
3	Tuberculosis (Tuberculoses) 01/2018 - 08/2012
3	Disease Progression 04/2011 - 01/2007
3	Candidiasis (Moniliasis) 07/2005 - 01/2002
3	Visceral Leishmaniasis (Kala Azar) 01/2003 - 01/2002
2	Vomiting 02/2021 - 12/2010
2	Arthralgia (Joint Pain) 02/2021 - 12/2010
2	Nausea 02/2021 - 12/2010
2	Neoplasms (Cancer) 12/2020 - 05/2010
2	Necrosis 12/2020 - 01/2020
2	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 12/2018 - 01/2006
2	Skin Ulcer 01/2018 - 01/2002
2	Parasitic Diseases (Parasitic Disease) 01/2018 - 09/2011
2	Leukemia 01/2017 - 03/2015
2	Communicable Diseases (Infectious Diseases) 09/2011 - 10/2008
2	Abdominal Pain (Pain, Abdominal) 12/2010 - 01/2002
2	HTLV-I Infections (HTLV-I Infection) 10/2008 - 01/2004
1	Myalgia 02/2021
1	Obesity 01/2021
1	Portal Hypertension 01/2021
1	Overweight 01/2021
1	Bacterial Infections (Bacterial Infection) 12/2020
1	Hepatitis C 02/2017

Drug/Important Bio-Agent (IBA)

36	CytokinesIBA 03/2024 - 01/2002
30	AntigensIBA 03/2024 - 12/2002
17	Interleukin-10 (Interleukin 10)IBA 01/2021 - 01/2002
14	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2015 - 01/2002
13	AntimonyIBA 11/2022 - 11/2004
9	Interleukin-5 (Interleukin 5)IBA 01/2021 - 01/2002
6	ChemokinesIBA 03/2024 - 09/2011
6	Interleukin-17 (Interleukin 17)IBA 12/2023 - 07/2009
6	Interleukin-6 (Interleukin 6)IBA 01/2023 - 08/2006
6	Interferon-gamma (Interferon, gamma)IBA 03/2015 - 01/2002
5	Immunoglobulin G (IgG)IBA 11/2022 - 02/2012
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2021 - 01/2002
5	miltefosine (Impavido)IBA 10/2021 - 12/2010
4	AntibodiesIBA 07/2023 - 01/2002
4	Meglumine AntimoniateIBA 04/2023 - 01/2018
4	Pentoxifylline (Trental)FDA LinkGeneric 11/2022 - 03/2007
4	Interleukin-13IBA 01/2021 - 01/2004
4	InterleukinsIBA 07/2015 - 01/2004
3	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2018
3	VaccinesIBA 04/2022 - 01/2002
3	InflammasomesIBA 01/2021 - 01/2017
3	HLA-DR Antigens (HLA-DR)IBA 01/2018 - 01/2014
3	AllergensIBA 02/2017 - 05/2003
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 11/2015
3	Immunoglobulin E (IgE)IBA 04/2004 - 01/2002
2	PlasticsIBA 01/2024 - 01/2023
2	Dinoprostone (PGE2)FDA Link 12/2023 - 12/2020
2	Granzymes (Granzyme)IBA 04/2022 - 01/2020
2	Interleukin-12 (IL 12)IBA 04/2022 - 01/2014
2	Interleukin-4 (Interleukin 4)IBA 01/2021 - 11/2004
2	Immunologic Factors (Immunomodulators)IBA 01/2021 - 01/2016
2	InterferonsIBA 12/2020 - 01/2018
2	Cholinergic Antagonists (Anticholinergics)IBA 03/2018 - 04/2007
2	Fluconazole (Zonal)FDA LinkGeneric 01/2017 - 07/2005
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 12/2002
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016 - 02/2007
2	Tuberculin (PPD)IBA 08/2012 - 09/2003
2	Interleukin-10 ReceptorsIBA 01/2009 - 12/2005
1	LigandsIBA 01/2024
1	EicosanoidsIBA 12/2023
1	succinylated wheat germ agglutininIBA 01/2023
1	Glycoproteins (Glycoprotein)IBA 12/2022
1	Salivary Proteins and PeptidesIBA 11/2022
1	CelluloseIBA 01/2022
1	Pioglitazone (Actos)FDA Link 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 12/2021
1	Macrophage Colony-Stimulating FactorIBA 02/2021
1	LeptinIBA 01/2021
1	Leukotriene B4IBA 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 12/2020
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	Glyburide (Glibenclamide)FDA LinkGeneric 01/2020
1	PerforinIBA 01/2020
1	Tyr sulfate(1)- enkephalinamide-Leu (LETS)IBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019
1	Viral AntigensIBA 01/2019
1	Pyrin Domain-Containing 3 Protein NLR FamilyIBA 01/2018
1	Interleukin-12 Subunit p40IBA 01/2018
1	Tamoxifen FDA LinkGeneric 01/2018

Therapy/Procedure

16	Therapeutics 10/2023 - 01/2003
2	Aftercare (After-Treatment) 03/2016 - 05/2009
1	Precision Medicine 11/2019
1	Physical Therapy Modalities (Physical Therapy Technique) 03/2018
1	Conservative Treatment 03/2018
1	Renal Dialysis (Hemodialysis) 02/2017